Stay updated on bb21217 Efficacy in Myeloma Clinical Trial

Sign up to get notified when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the bb21217 Efficacy in Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the completed bb21217 Phase 1 multiple myeloma study, including its eligibility criteria, treatment, outcomes, locations, and dates.
    Difference
    45%
    Check dated 2026-11-10T16:49:31.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T16:58:30.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study page itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T19:07:30.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T18:54:40.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details content. The site header/footer remain, but the core trial information and navigation are no longer accessible, indicating restricted access.
    Difference
    17%
    Check dated 2026-09-22T22:00:23.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page's revision line was updated from Revision: v3.6.6 to Revision: v3.7.0, indicating a new build or update applied to the page. This is a metadata change reflecting an update to the site rather than content changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T22:26:55.000Z thumbnail image

Stay in the know with updates to bb21217 Efficacy in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.